TY - JOUR
T1 - Metabolic syndrome and risk factors for cardiovascular disease
T2 - Are nonagenarians protected?
AU - Frisard, Madlyn I.
AU - Rood, Jennifer C.
AU - Fang, Xiaobing
AU - Su, Joseph
AU - Welsh, David A.
AU - Jazwinski, S. Michal
AU - Ravussin, Eric
N1 - Funding Information:
Support This research was supported by the Louisiana Board of Regents through the Millennium Trust Health Excellence Fund [HEF(2001–06)-02], by the National Institute on Aging (P01AG022064), and by the National Institute of General Medical Sciences (GM42056 and GM15431).
PY - 2009/3
Y1 - 2009/3
N2 - This study assessed cardiovascular disease risk factors in three groups of human subjects aged 20-34 [young, 20 male (M)/33 female (F)], 60-74 (aged, 29M/29F), and > 90 years (nonagenarian, 47M/50F). Components of the metabolic syndrome, cardiovascular disease, and markers of inflammation and oxidative stress were assessed. Nonagenarians weighed less than the two other groups (P∈<∈0.001); however, there was no difference in percent fat among the three groups. Aged individuals had the highest prevalence of the metabolic syndrome (P∈<∈0.001) according to the Adult Treatment Panel III classification. Both fibrinogen and homocysteine concentrations were significantly higher in the nonagenarians compared to younger groups. However, there were no significant differences between groups in fasting insulin, high sensitive C-reactive protein, and plasminogen activator inhibitor 1 concentrations. There were also no relationships between inflammation/ oxidative stress and the metabolic syndrome or cardiovascular disease although nonagenarians appear to be protected from oxidative damage to DNA.
AB - This study assessed cardiovascular disease risk factors in three groups of human subjects aged 20-34 [young, 20 male (M)/33 female (F)], 60-74 (aged, 29M/29F), and > 90 years (nonagenarian, 47M/50F). Components of the metabolic syndrome, cardiovascular disease, and markers of inflammation and oxidative stress were assessed. Nonagenarians weighed less than the two other groups (P∈<∈0.001); however, there was no difference in percent fat among the three groups. Aged individuals had the highest prevalence of the metabolic syndrome (P∈<∈0.001) according to the Adult Treatment Panel III classification. Both fibrinogen and homocysteine concentrations were significantly higher in the nonagenarians compared to younger groups. However, there were no significant differences between groups in fasting insulin, high sensitive C-reactive protein, and plasminogen activator inhibitor 1 concentrations. There were also no relationships between inflammation/ oxidative stress and the metabolic syndrome or cardiovascular disease although nonagenarians appear to be protected from oxidative damage to DNA.
KW - Aging
KW - Cardiovascular disease
KW - Inflammation
KW - Metabolic syndrome
KW - Oxidative stress
UR - http://www.scopus.com/inward/record.url?scp=60849096636&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=60849096636&partnerID=8YFLogxK
U2 - 10.1007/s11357-008-9082-z
DO - 10.1007/s11357-008-9082-z
M3 - Article
C2 - 19234770
AN - SCOPUS:60849096636
SN - 0161-9152
VL - 31
SP - 67
EP - 75
JO - Age
JF - Age
IS - 1
ER -